Back to top

Image: Bigstock

Should You Buy Oncobiologics, Inc. (OTLK) After Golden Cross?

Read MoreHide Full Article

From a technical perspective, Oncobiologics, Inc. (OTLK - Free Report) is looking like an interesting pick, as it just reached a key level of support. OTLK's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

There's a reason traders love a golden cross -- it's a technical chart pattern that can indicate a bullish breakout is on the horizon. This kind of crossover is formed when a stock's short-term moving average breaks above a longer-term moving average. Typically, a golden cross involves the 50-day and the 200-day moving averages, since bigger time periods tend to form stronger breakouts.

There are three stages to a golden cross. First, there must be a downtrend in a stock's price that eventually bottoms out. Then, the stock's shorter moving average crosses over its longer moving average, triggering a positive trend reversal. The third stage is when a stock continues the upward momentum to higher prices.

This kind of chart pattern is the opposite of a death cross, which is a technical event that suggests future bearish price movement.

Over the past four weeks, OTLK has gained 38%. The company currently sits at a #2 (Buy) on the Zacks Rank, also indicating that the stock could be poised for a breakout.

The bullish case only gets stronger once investors take into account OTLK's positive earnings outlook for the current quarter. There have been 3 upwards revisions compared to none lower over the past 60 days, and the Zacks Consensus Estimate has moved up as well.

Moving Average Chart for OTLK

Given this move in earnings estimates and the positive technical factor, investors may want to keep their eye on OTLK for more gains in the near future.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Oncobiologics, Inc. (OTLK) - free report >>

Published in